newsfilter
← Latest News
PR Newswire·

Leap Therapeutics Announces Reverse Stock Split

CAMBRIDGE, Mass., June 20, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it will effect a